A Look At Stryker (SYK) Valuation As Q1 2026 Earnings And Cyberattack Recovery Draw Investor Focus

Simply Wall St.04-22

Stryker (SYK) heads into its upcoming Q1 2026 earnings report with investor attention centered on expected profit growth, recent cyberattack recovery efforts, and the latest leadership move inside its...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2629541380?lang=en_US&edition=fundamental","thumbnail":"https://images.simplywall.st/asset/company-cover/94614-main-header/1756253509683","is_english":true,"pubTime":"2026-04-22 02:07","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2629541380","market":"us","top_or_hot":-1,"title":"A Look At Stryker (SYK) Valuation As Q1 2026 Earnings And Cyberattack Recovery Draw Investor Focus","media":"Simply Wall St.","content":"<div>\n<p>Stryker (SYK) heads into its upcoming Q1 2026 earnings report with investor attention centered on expected profit growth, recent cyberattack recovery efforts, and the latest leadership move inside its...</p>\n\n<a href=\"https://simplywall.st/stocks/us/healthcare/nyse-syk/stryker/news/a-look-at-stryker-syk-valuation-as-q1-2026-earnings-and-cybe\">Source Link</a>\n\n</div>\n","source":"simplywall_highlight","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>A Look At Stryker (SYK) Valuation As Q1 2026 Earnings And Cyberattack Recovery Draw Investor Focus</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nA Look At Stryker (SYK) Valuation As Q1 2026 Earnings And Cyberattack Recovery Draw Investor Focus\n</h2>\n\n<h4 class=\"meta\">\n\n\n2026-04-22 02:07 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://simplywall.st/stocks/us/healthcare/nyse-syk/stryker/news/a-look-at-stryker-syk-valuation-as-q1-2026-earnings-and-cybe><strong>Simply Wall St.</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Stryker (SYK) heads into its upcoming Q1 2026 earnings report with investor attention centered on expected profit growth, recent cyberattack recovery efforts, and the latest leadership move inside its...</p>\n\n<a href=\"https://simplywall.st/stocks/us/healthcare/nyse-syk/stryker/news/a-look-at-stryker-syk-valuation-as-q1-2026-earnings-and-cybe\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"SYK","symbol_name":"史赛克","start_time":0,"source_url":"https://simplywall.st/stocks/us/healthcare/nyse-syk/stryker/news/a-look-at-stryker-syk-valuation-as-q1-2026-earnings-and-cybe","article_id":"2629541380","we_media_id":null,"thumbnails":["https://images.simplywall.st/asset/company-cover/94614-main-header/1756253509683"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/healthcare/nyse-syk/stryker/news/a-look-at-stryker-syk-valuation-as-q1-2026-earnings-and-cybe","rn_cache_url":null,"directOrigin":true},"url":"https://stock-news.laohu8.com/highlight/detail?id=2629541380","pubTimestamp":1776794849,"columns":[],"sourceInfo":{"source_id":"simplywall_highlight","name":"Simply Wall St."},"weMediaInfo":null,"summary":"Stryker (SYK) heads into its upcoming Q1 2026 earnings report with investor attention centered on expected profit growth, recent cyberattack recovery efforts, and the latest leadership move inside its MedSurg and Neurotechnology segment.\nSee our latest analysis for Stryker.\nDespite the recent leadership change and attention on cyberattack recovery, Stryker’s 1 day share price return of a 1.45% decline and 7 day share price return of a 2.56% decline sit alongside a modest 1 year total...","collect":0,"end_time":0,"defaultTopTitle":"simplywall.st","property":["earning"],"viewcount":null,"language":"en","relate_stocks":{"SYK":"史赛克"},"translate_title":"随着2026年第一季度收益和网络攻击恢复引起投资者关注，Stryker(SYK)估值一览","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"SYK":1.5},"content_text":"Stryker (SYK) heads into its upcoming Q1 2026 earnings report with investor attention centered on expected profit growth, recent cyberattack recovery efforts, and the latest leadership move inside its MedSurg and Neurotechnology segment. See our latest analysis for Stryker. Despite the recent leadership change and attention on cyberattack recovery, Stryker’s 1 day share price return of a 1.45% decline and 7 day share price return of a 2.56% decline sit alongside a modest 1 year total shareholder return of 0.59%. This points to fading near term momentum but still positive multi year gains, with a 5 year total shareholder return of 34.31%. If the upcoming earnings update has you reassessing healthcare exposure, it can be useful to see what else is gaining attention in the sector through our screener of 35 healthcare AI stocks With Stryker trading near $338.34, sitting on modest 1 year gains but a stronger 5 year record, the key question is whether recent weakness leaves shares underappreciated or if the market already reflects expectations for future growth. AdvertisementMost Popular Narrative: 4.6% Overvalued Against the last close of $338.34, the most followed narrative on Stryker pegs fair value at about $323, suggesting the current price sits above that estimate.  Stryker has a solid balance sheet, I always want to see more equity than debt, which is the case with $19.2b (equity) versus $12.9b (debt) and leads to a debt to equity ratio of 67%. If we even take the cash position into account, which is $2.4b, the debt may be reduced to $10.5b, and we end up with a net debt to equity ratio of 54%.  Read the complete narrative. Want to see how this balance sheet story feeds into the valuation call? The narrative leans on future earnings power, richer free cash flows and higher returns on equity. The connective tissue is a tighter link between cash generation and long term compounding. The full breakdown shows exactly how those assumptions build to that fair value mark. Result: Fair Value of $323.52 (OVERVALUED) Have a read of the narrative in full and understand what's behind the forecasts. However, recent cyberattack recovery efforts and any earnings disappointment around the Q1 2026 update could quickly challenge assumptions behind this fair value story. Find out about the key risks to this Stryker narrative. Another Take: Market Pricing vs Cash Flow The popular narrative pegs fair value at about $323 using its own discounted cash flow view and calls Stryker overvalued. Our DCF model, however, points to a fair value of $344.81 with the shares at $338.34, which is slightly below that mark. With the SWS DCF model suggesting Stryker is trading 1.9% under its fair value, while some investors still see a premium, the key question is which set of assumptions you trust more around future cash generation and risk. Look into how the SWS DCF model arrives at its fair value. SYK Discounted Cash Flow as at Apr 2026Simply Wall St performs a discounted cash flow (DCF) on every stock in the world every day (check out Stryker for example). We show the entire calculation in full. You can track the result in your watchlist or portfolio and be alerted when this changes, or use our stock screener to discover 63 high quality undervalued stocks. If you save a screener we even alert you when new companies match - so you never miss a potential opportunity. Next Steps If this mix of confidence and caution around Stryker feels familiar, take a closer look at the full picture now and weigh the 4 key rewards and 2 important warning signs Looking for more investment ideas? If Stryker is already on your radar, do not stop there. Broaden your watchlist with fresh opportunities that fit different goals and risk profiles across the market.  Target long term compounding potential by scanning companies that pair quality fundamentals with attractive pricing using the 63 high quality undervalued stocks. Build a steadier income stream by reviewing businesses with robust payouts through the 13 dividend fortresses. Stay on the front foot by tracking financially resilient names highlighted in the 72 resilient stocks with low risk scores.   This article by Simply Wall St is general in nature. We provide commentary based on historical data\n    and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your\n    financial situation. We aim to bring you long-term focused analysis driven by fundamental data.\n    Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material.\n    Simply Wall St has no position in any stocks mentioned.New: Manage All Your Stock Portfolios in One PlaceWe've created the ultimate portfolio companion for stock investors, and it's free.• Connect an unlimited number of Portfolios and see your total in one currency• Be alerted to new Warning Signs or Risks via email or mobile• Track the Fair Value of your stocksTry a Demo Portfolio for FreeHave feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.42.0","shortVersion":"4.42.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2629541380","isCrawlerRequest":true}